Overview Request Sample Pages Request Customization Download PDF
You are viewing: Mexico Immunoassay Market analysis
Part of: Immunoassay Market (Global)

The Mexico Immunoassay Market was valued at $348.92 Million in 2025 and projected to reach to $439.85 Million by 2030, representing a compound annual growth rate of 4.7%. Mexico's immunoassay market is positioned for steady growth through 2030, driven by expanding healthcare accessibility and modernization of diagnostic infrastructure across the country.

Mexico Immunoassay Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Immunoassay Market Trends and Insights

  • This steady growth reflects Mexico's increasing healthcare infrastructure investments and rising demand for diagnostic testing across clinical laboratories and hospitals.
  • Mexico's immunoassay sector benefits from growing prevalence of chronic diseases, expanding middle-class populations seeking preventive care, and modernization of diagnostic facilities in urban centers. The Mexican immunoassay market is driven by technological advancements in assay platforms, increased adoption of automated diagnostic systems, and strengthening regulatory frameworks that support quality standards.
  • Mexico's position as a regional healthcare hub in Latin America supports market expansion, with both domestic and international manufacturers establishing distribution networks.
  • Between 2025 and 2030, Mexico is expected to see accelerated adoption of point-of-care immunoassay testing and enhanced laboratory automation, positioning the country as a key growth market within the Latin American region..

Key Market Statistics

  • CAGR (2025-2030) 4.7% CAGR
  • Market Size, 2025 ~USD 348.92 Million
  • Forecast, 2030 ~USD 439.85 Million
  • Country Mexico

Mexico Immunoassay Market Overview

Market Valuation :

Mexico's immunoassay market is valued at USD 348.92 million in 2025, with projected growth to USD 439.85 million by 2030, representing a steady CAGR of 4.7%.

Healthcare Infrastructure Growth :

Increasing investments in Mexico's healthcare infrastructure are driving demand for advanced diagnostic testing capabilities across clinical laboratories, hospitals, and diagnostic centers nationwide.

Diagnostic Testing Expansion :

Rising prevalence of chronic diseases and infectious conditions in Mexico is fueling demand for immunoassay testing in both public and private healthcare settings.

Market Growth Drivers :

Mexico's immunoassay sector benefits from growing awareness of preventive healthcare, expanding laboratory networks, and increasing adoption of automated diagnostic systems in urban and emerging markets.

Mexico Immunoassay Market Dynamics

  • The 4.7% CAGR reflects Mexico's commitment to improving clinical laboratory capabilities and diagnostic accuracy in both metropolitan and regional healthcare facilities.
  • Increasing government healthcare initiatives and private sector investments are expected to enhance immunoassay adoption rates.
  • The market will benefit from rising disease prevalence, growing patient awareness, and technological advancements in diagnostic testing methodologies.
  • Mexico's strategic location and healthcare market maturity present significant opportunities for immunoassay manufacturers and diagnostic service providers seeking to expand their presence in Latin America..

Market Ecosystem

logo-mobile

IMMUNOASSAY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
 Provides automated immunoassay testing through the Alinity i and ARCHITECT systems for clinical laboratory and blood screening applications. Improves testing throughput within a compact footprint | Supports broad testing menus | Provides greater walk-away time through automated workflows | Supports consistent and reliable results.
company logo
 Provides automated immunoassay testing through cobas e analyzers using electrochemiluminescence technology across infectious disease, cardiac, endocrine, fertility, and oncology applications. Provides high sensitivity and reproducibility through ECL technology | Supports high-throughput testing | Enables continuous reagent loading during operation | Supports carryover-free sample processing.
company logo
 Provides immunoassay testing through Atellica IM, ADVIA Centaur, and IMMULITE systems across infectious disease, cardiac, endocrine, and reproductive health testing. Supports high immunoassay testing throughput | Enables rapid turnaround for key assays | Provides automated QC and remote monitoring | Supports broad assay menus and scalable laboratory configurations.
company logo
 Provides automated immunoassay testing through DxI and Access analyzers for clinical laboratories with varying testing volumes. Provides high productivity per laboratory footprint | Reduces routine maintenance requirements | Supports remote real-time system monitoring | Enables expanded assay processing and laboratory productivity.
company logo
 Provides Bio-Plex multiplex immunoassays and ELISA-based solutions for biomarker, cytokine, protein, and antibody analysis across research and clinical applications. Enables simultaneous measurement of multiple analytes | Reduces sample volume requirements | Supports high-throughput biomarker analysis | Provides automated data analysis and reproducible assay performance.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Mexico's immunoassay market reaches USD 348.92 million in 2025 with projected growth to USD 439.85 million by 2030.
      • Mexico experiences a 4.7% CAGR, driven by healthcare infrastructure modernization and increased diagnostic demand.
      • Mexico's growing chronic disease burden and expanding middle-class populations fuel demand for immunoassay testing.
      • Mexico is positioned as a regional healthcare hub, attracting both domestic and international diagnostic manufacturers.

      Immunoassay Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment CLIA (Technology)
      Forecast Period 2025–2030
      Growth Rate CAGR of 6.1% from 2025 to 2030
      Largest Segment REAGENTS & KITS (Product)
      Market Size Base Year (Billions) ~USD 35.48 (2025)
      Revenue Forecast (Billions) ~USD 47.7 (2030)
      Segments Covered Product, Type, Purchase Mode, Technology, Specimen, Application

      Mexico Immunoassay Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product

      • Analyzers
      • Reagents & Kits

      By Type

      • Clia Reagents & Kits
      • Closed-Ended Systems
      • Elisa Reagents & Kits
      • Elispot Reagents & Kits
      • Ifa Reagents & Kits
      • Open-Ended Systems
      • Other Reagents & Kits
      • Rapid Test Reagents & Kits
      • Western Blot Reagents & Kits

      By Purchase Mode

      • Outright Purchase
      • Rental Purchase

      By Technology

      • Clia
      • Elisa
      • Elispot
      • Ifa
      • Other Technologies
      • Rapid Tests
      • Western Blotting

      By Specimen

      • Blood
      • Other Specimens
      • Saliva
      • Urine

      By Application

      • Allergy Diagnostics
      • Autoimmune Disorders
      • Blood Screening
      • Bone & Mineral Disorders
      • Cardiology
      • Drug Monitoring & Testing
      • Endocrinology
      • Infectious Diseases
      • Newborn Screening
      • Oncology
      • Other Applications

      MEXICO: IMMUNOASSAY MARKET, BY END USER, 2023–2030

      Segment2023202420252026202820292030CAGR (%)
      BLOOD BANKS10.6410.6210.6910.911.6112.1312.793.7
      CLINICAL LABORATORIES113.38114.35116.45119.97130.66138.09147.184.8
      HOME CARE SETTINGS14.1614.1914.3714.7215.8316.6417.624.2
      HOSPITALS & CLINICS267.11268.78273.1280.71304.31320.89341.224.6
      TOTAL405.29407.94414.61426.3462.41487.75518.814.6

      Target Audience

      • Diagnostic Equipment Manufacturers : Manufacturers need Mexico-specific market data to assess market size, growth potential, and competitive landscape for immunoassay analyzer and reagent distribution strategies.
      • Healthcare Facility Operators : Hospital and laboratory administrators require market insights to justify immunoassay technology investments, benchmark against regional trends, and optimize diagnostic service offerings.
      • In Vitro Diagnostics Companies : IVD manufacturers and distributors need Mexico market intelligence to identify growth opportunities, plan product launches, and develop localized commercial strategies.
      • Healthcare Investors & Consultants : Investment firms and management consultants require detailed Mexico market analysis to evaluate healthcare sector opportunities, assess portfolio companies, and guide strategic decisions.
      • Regulatory & Policy Advisors : Healthcare policy experts and regulatory consultants need market data to understand Mexico's diagnostic testing landscape, inform healthcare policy recommendations, and identify sector trends.

      Key Companies in the Mexico Immunoassay Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug Product Services (oral, sterile, packaging, lifecycle),Pharmaceutical Development Services (preclinical to clinical),Drug Substance Services (small-molecule and biologics APIs),
      ALERE INCUnited StatesPrivate CompanyInfectious disease diagnostics (rapid and serology, including ELISA and automated systems),Cardiometabolic and critical care point-of-care (blood gas, lipids, glucose, D-dimer, troponin, diabetes),Toxicology and workplace drug testing (devices, reagents, lab services, alcohol tests),
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining and metals, infrastructure, staffing, maintenance),Mission Solutions (government, nuclear remediation, nuclear security, logistics, mission-critical O&M),
      CEPHEID INC.United StatesPrivate CompanyInfectious disease & healthcare-associated infection assays (Xpert on GeneXpert),Virology assays (including emergency use authorization tests),Oncology and genetics assays,
      IMMUCOR, INC.United StatesPrivate CompanyTransfusion (serology instruments and reagents, including NEO, Echo, Capture),Transplant & Molecular (HLA, HPA assays, Array Imaging System, BASIS, platelet-focused products),Other / Services and Ancillary Products,
      UNILABSSwitzerlandPrivate CompanyRoutine & Specialty Laboratory Testing,Medical Imaging,Pathology & Centres of Excellence (IVF, Fertility, Pregnancy, Targeted Diagnostics),
      EIKEN CHEMICAL CO., LTD.JapanPublic CompanyFecal immunochemical test (FIT) reagents and analyzers,Microbiological reagents and food/environmental microbiology,Urinalysis test strips and analyzers,
      ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
      SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
      DANAHERUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (analytical instruments, genomics, and lab automation),Diagnostics (clinical instruments and consumables),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      REVVITYUnited StatesPublic CompanyDiagnostics instruments and systems,Diagnostics reagents, assays, and consumables,Life science reagents and genomic workflow tools,
      DIASORIN S.P.A.ItalyPublic CompanyImmunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology, Metabolic Disorders, Tumor Markers, Oncology,Molecular Diagnostics – Simplexa and Congenital CMV,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research Tools,Other / Informatics & Software,
      QUIDELORTHO CORPORATIONUnited StatesPublic CompanyLabs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care,
      BIOMÉRIEUXFrancePublic CompanyClinical microbiology & AST (VITEK, CHROMID, ETEST, culture media, BACT/ALERT),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays & biomarkers (VIDAS, Hybiome CLIA),
      QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Molecular diagnostics assays (TB, immune response, oncology, sexual and reproductive health),Research PCR and enzymes (qPCR, digital PCR, RT-PCR, configured solutions),
      SYSMEX CORPORATIONJapanPublic CompanyHematology analyzers & reagents,Coagulation diagnostics,Urinalysis, blood gas, electrolyte,
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring and life support (monitoring, ventilators, defibrillation, AED, anesthesia),Ultrasound and medical imaging (ultrasound, radiology, endoscope camera system),In-vitro diagnostics (CLIA, chemistry, hematology, laboratory diagnostics),

      PATHEON INC

      Patheon Inc. is a Netherlands-based pharmaceutical manufacturing company with 9,100 employees. Operating as a private company, it provides contract development and manufacturing services to the pharmaceutical industry.

      ALERE INC

      Alere Inc. is a United States-based diagnostics company founded in 1981 with 9,700 employees. Operating as a private company, it specializes in rapid diagnostic testing solutions for healthcare markets.

      FLUOR CORPORATION

      Fluor Corporation is a United States-based engineering and construction company founded in 1912 with 22,995 employees. As a public company, it provides design, engineering, procurement, and construction services across multiple industries.

      CEPHEID INC.

      Cepheid Inc. is a United States-based molecular diagnostics company founded in 1996 with 1,700 employees. Operating as a private company, it develops and manufactures automated molecular testing systems.

      IMMUCOR, INC.

      Immucor, Inc. is a United States-based immunohematology company founded in 1982 with 1,125 employees. As a private company, it specializes in blood bank and transfusion medicine diagnostic solutions.

      UNILABS

      Unilabs is a Switzerland-based clinical laboratory services company founded in 1987 with 1,897 employees. As a private company, it operates diagnostic laboratories across multiple European countries.

      EIKEN CHEMICAL CO., LTD.

      Eiken Chemical Co., Ltd. is a Japan-based diagnostics and pharmaceutical company founded in 1939 with 696 employees. As a public company, it manufactures in vitro diagnostic reagents and pharmaceutical products.

      ABBOTT

      Abbott is a United States-based healthcare company founded in 1888 with 115,000 employees. As a public company, it develops and manufactures diagnostics, medical devices, pharmaceuticals, and nutritional products.

      SIEMENS HEALTHINEERS AG

      Siemens Healthineers AG is a Germany-based medical technology company founded in 1896 with 72,369 employees. As a public company, it manufactures and distributes diagnostic imaging, laboratory diagnostics, and point-of-care testing systems.

      DANAHER

      Danaher is a United States-based conglomerate founded in 1969 with 59,000 employees. As a public company, it operates across multiple sectors including life sciences, diagnostics, and environmental solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based life sciences company founded in 1956 with 125,000 employees. As a public company, it provides laboratory equipment, reagents, and analytical instruments globally.

      REVVITY

      Revvity is a United States-based life sciences and diagnostics company founded in 1937 with 11,000 employees. As a public company, it manufactures and distributes analytical instruments and reagents for research and diagnostics.

      DIASORIN S.P.A.

      DiaSorin S.p.A. is an Italy-based diagnostics company founded in 1968 with 3,242 employees. As a public company, it develops and manufactures in vitro diagnostic products for clinical laboratories.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based life sciences company founded in 1952 with 7,450 employees. As a public company, it manufactures and distributes reagents, instruments, and quality control products for clinical and research laboratories.

      QUIDELORTHO CORPORATION

      QuidelOrtho Corporation is a United States-based diagnostics company founded in 1979 with 6,500 employees. As a public company, it develops and manufactures rapid diagnostic tests and laboratory instruments.

      BIOMÉRIEUX

      bioMérieux is a France-based diagnostics company founded in 1963 with 14,894 employees. As a public company, it specializes in in vitro diagnostics for infectious diseases, industrial microbiology, and clinical diagnostics.

      QIAGEN

      QIAGEN is a Netherlands-based molecular diagnostics company founded in 1984 with 5,500 employees. As a public company, it develops and manufactures sample preparation and molecular testing solutions.

      SYSMEX CORPORATION

      Sysmex Corporation is a Japan-based diagnostics company founded in 1968 with 10,861 employees. As a public company, it manufactures and distributes hematology, hemostasis, and clinical chemistry analyzers.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based life sciences and diagnostics company founded in 1999 with 18,000 employees. As a public company, it provides analytical instruments, software, and services for research and diagnostics.

      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

      Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a China-based medical device company founded in 1991 with 21,288 employees. As a public company, it manufactures and distributes diagnostic imaging, patient monitoring, and laboratory instruments globally.

      Reasons to Buy this Report

      • Market-Specific Sizing Data : Access precise valuation figures for Mexico's immunoassay market (USD 348.92M in 2025) with detailed 5-year forecasts enabling accurate business planning and investment decisions.
      • Growth Trajectory Analysis : Understand Mexico's 4.7% CAGR in context of global 6.1% growth, identifying localized opportunities and competitive advantages specific to the Mexican healthcare landscape.
      • Healthcare Infrastructure Insights : Gain intelligence on Mexico's expanding clinical laboratory networks, hospital diagnostic capabilities, and infrastructure investments driving immunoassay demand across regions.
      • Competitive Positioning Strategy : Develop targeted market entry and expansion strategies for Mexico by understanding local healthcare dynamics, regulatory environment, and diagnostic testing adoption patterns.
      • Investment Decision Support : Make informed capital allocation decisions for Mexico operations with comprehensive market data, growth projections, and sector-specific trends through 2030.

      Frequently asked questions

      What is the current size of Mexico's immunoassay market?

      Mexico's immunoassay market is valued at USD 348.92 million in 2025.

      What is the projected market size for Mexico's immunoassay sector by 2030?

      Mexico's immunoassay market is forecast to reach USD 439.85 million by 2030.

      What is the growth rate of Mexico's immunoassay market?

      Mexico's immunoassay market is expected to grow at a CAGR of 4.7% from 2025 to 2030.

      What factors are driving growth in Mexico's immunoassay market?

      Key drivers include healthcare infrastructure modernization, rising chronic disease prevalence, expanding middle-class populations, technological advancements in diagnostic platforms, and increased laboratory automation adoption across Mexico.

      Why is Mexico important for the Latin American immunoassay market?

      Mexico serves as a regional healthcare hub in Latin America, attracting both domestic and international manufacturers and supporting broader market expansion across the region.

      RESEARCH METHODOLOGY

      This study analyzes key market dynamics, including drivers, opportunities, restraints, and challenges, as well as major players’ strategies. It also monitors developments among leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study examines the immunoassay market’s competitive landscape by evaluating market participants against criteria within the overarching categories of business and product strategy. To estimate market size, the study employed both top-down and bottom-up approaches. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.
      The four steps involved in estimating the market size are as follows:

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

      Primary Research

      In the primary research process, we interviewed various sources from the supply and demand sides to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. We conducted in-depth interviews with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

      The following is a breakdown of the primary respondents:

      Immunoassay Market Size, and Share

      Note 1: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
      Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
      Note 3: Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For global market value, we calculated annual revenue figures using revenue mapping for major product manufacturers and OEMs active in the global immunoassay market. We identified all major product manufacturers at the global and/or country/regional level. We mapped revenue for the respective business segments/subsegments of the major players. Additionally, the global market was split into various segments and subsegments:

      • List of major players in the immunoassay market by region or country
      • Product mapping of various immunoassay manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from immunoassay products (or the nearest reported business unit/product category)
      • Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
      • Summation of revenue of all companies to arrive at the global immunoassay market size

      The data above was consolidated, supplemented with detailed inputs and analysis from MarketsandMarkets, and presented in this report.

      Immunoassay Market: Top-Down and Bottom-Up Approach

      Immunoassay Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall market size using the market size estimation processes, we split the market into several segments and subsegments. To complete the overall market engineering process and arrive at precise statistics for each market segment and subsegment, we used data triangulation and market breakdown procedures, where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides of the immunoassay industry.

      Market Definition

      An immunoassay is a biochemistry-based test that quantifies the presence or concentration of an analyte. An analyte can be a large protein or antibody produced due to an infection. Immunoassays have become popular and well-established procedures in laboratories. They provide quick, accurate, and precise results. This technique is mostly used in clinical diagnostics, drug monitoring, drug discovery, and food testing.

      Key Stakeholders

      • Manufacturers and vendors of immunoassay instruments and consumables
      • Immunoassay product manufacturers
      • Pharmaceutical & biopharmaceutical players
      • Diagnostic associations
      • Research associations involved in infectious and chronic disease research
      • Various research and consulting firms
      • Distributors of immunoassay instruments and consumables
      • Contract manufacturers of immunoassays
      • Healthcare institutions
      • Research institutes
      • Clinical laboratories

      Report Objectives

      • To describe, segment, and forecast the immunoassay market by product, technology, specimen, application, end user, and region in terms of value
      • To forecast the size of the immunoassay market in five main regions (along with their respective key countries): North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
      • To provide detailed information about the factors (drivers, restraints, opportunities, and challenges) influencing market growth
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall immunoassay market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To profile the key players in the immunoassay market and comprehensively analyze their core competencies and market shares
      • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the market
      • To benchmark players within the immunoassay market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

      Available customizations:

      Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:

      Geographict Analysis

      • Further breakdown of the Rest of Europe immunoassay market into Switzerland, Denmark, Austria, and others

      • Further breakdown of the Rest of Asia Pacific immunoassay market into Hong Kong, Taiwan, and others

      • Further breakdown of the Rest of Latin America immunoassay market into Argentina, Colombia, Chile, Ecuador, and others

      • Further breakdown of the Southeast Asian immunoassay market into Malaysia, Singapore, Australia, New Zealand, and others

      Competitive Landscape Assessment

      • Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the immunoassay market

      • Competitive leadership mapping for established players in the US

      Get the Full Immunoassay Market Report

      Full forecast, segment splits, and company analysis for all Immunoassay Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status